Bio

Joe Munda has worked in finance and investment for 16 years and joined First Analysis in 2015. He works with entrepreneurs as an investor and as an advisor on growth transactions to help build leading businesses in healthcare technology. He has played a key role in building First Analysis’ franchises in drug development technology and medical technology and has published several thought-leading white papers in those areas. He supports First Analysis' investments in Checkpoint Surgical, Medicinal Genomics, Transformative Pharmaceutical Solutions, VIDA Diagnostics and Yunu. Prior to joining First Analysis, he was an equity research analyst covering medical device and healthcare services companies at Sidoti & Co. Earlier, he worked in institutional sales at Bear Stearns/J.P. Morgan. He earned a bachelor's degree in finance from Fairleigh Dickinson University.